• Consensus Rating: Moderate Buy
  • Consensus Price Target: $101.83
  • Forecasted Upside: 21.62%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$83.73
▲ +0.79 (0.95%)

This chart shows the closing price for DOX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Amdocs Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DOX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DOX

Analyst Price Target is $101.83
▲ +21.62% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Amdocs in the last 3 months. The average price target is $101.83, with a high forecast of $111.00 and a low forecast of $90.00. The average price target represents a 21.62% upside from the last price of $83.73.

This chart shows the closing price for DOX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 6 contributing investment analysts is to moderate buy stock in Amdocs. This rating has held steady since April 2024, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/30/2023
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/26/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/24/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/24/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/22/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/21/2024
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
11/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/14/2024BarclaysLower TargetOverweight ➝ Overweight$113.00 ➝ $111.00
11/13/2024OppenheimerBoost TargetOutperform ➝ Outperform$98.00 ➝ $105.00
10/2/2024Stifel NicolausInitiated CoverageBuy$100.00
5/9/2024CitigroupLower TargetBuy ➝ Buy$105.00 ➝ $100.00
5/9/2024Robert W. BairdLower TargetNeutral ➝ Neutral$97.00 ➝ $90.00
2/8/2024BarclaysBoost TargetOverweight ➝ Overweight$105.00 ➝ $115.00
1/17/2024CitigroupBoost TargetBuy ➝ Buy$96.00 ➝ $104.00
12/1/2023Jefferies Financial GroupInitiated CoverageBuy$105.00
8/3/2023OppenheimerBoost TargetOutperform ➝ Outperform$99.00 ➝ $109.00
6/16/2023Bank of AmericaBoost Target$100.00 ➝ $110.00
5/16/2023BarclaysUpgradeEqual Weight ➝ Overweight$100.00 ➝ $115.00
5/11/2023888Reiterated RatingReiterates
2/2/2023Robert W. BairdBoost TargetNeutral$85.00 ➝ $100.00
2/1/2023OppenheimerBoost TargetOutperform$94.00 ➝ $99.00
11/15/2022BarclaysBoost Target$100.00
11/15/2022Robert W. BairdLower Target$85.00
11/10/2022OppenheimerReiterated RatingOutperform ➝ Outperform$84.00
11/9/2022OppenheimerLower Target$99.00 ➝ $94.00
11/9/2022CitigroupLower TargetBuy$99.00 ➝ $96.00
8/4/2022CitigroupBoost TargetBuy$90.00 ➝ $99.00
8/4/2022BarclaysBoost TargetEqual Weight$89.00 ➝ $95.00
5/13/2022OppenheimerReiterated RatingOutperform ➝ Top Pick
5/12/2022CitigroupLower Target$93.00 ➝ $90.00
12/14/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$91.00 ➝ $86.00
8/5/2021OppenheimerBoost TargetOutperform$84.00 ➝ $99.00
4/9/2021OppenheimerReiterated RatingBuy
2/11/2021OppenheimerReiterated RatingOutperform$84.00
2/3/2021CitigroupBoost Target$82.00 ➝ $87.00
11/11/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$75.00
8/12/2020OppenheimerReiterated RatingBuy$75.00
8/6/2020OppenheimerReiterated RatingBuy$75.00
5/11/2020CitigroupLower TargetBuy$83.00 ➝ $76.00
2/5/2020OppenheimerBoost TargetOutperform$77.00 ➝ $85.00
2/5/2020Robert W. BairdBoost TargetNeutral$69.00 ➝ $74.00
1/15/2020CitigroupBoost TargetBuy$72.00 ➝ $83.00
(Data available from 11/21/2019 forward)

News Sentiment Rating

0.61 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 16 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2024
  • 20 very positive mentions
  • 10 positive mentions
  • 6 negative mentions
  • 1 very negative mentions
5/25/2024
  • 19 very positive mentions
  • 2 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
6/24/2024
  • 14 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2024
  • 17 very positive mentions
  • 7 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
8/23/2024
  • 21 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/22/2024
  • 21 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/22/2024
  • 18 very positive mentions
  • 16 positive mentions
  • 11 negative mentions
  • 0 very negative mentions
11/21/2024

Current Sentiment

  • 18 very positive mentions
  • 16 positive mentions
  • 11 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Amdocs logo
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers. It also offers AI-powered, cloud-native, and home operating systems; data intelligence solutions and applications; end-to-end application development and maintenance services; and ongoing maintenance services. In addition, the company provides a line of services designed for various stages of a service provider's lifecycle includes consulting, delivery, quality engineering, operations, systems integration, network services, experience-driven services, data, cloud, and content services; managed services comprising application development, modernization and maintenance, IT and infrastructure services, testing and professional services that are designed to assist customers in the selection, implementation, operation, management, and maintenance of IT systems. It serves to the communications, entertainment, and media industry service providers, as well as mobile virtual network operators. Amdocs Limited was founded in 1988 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $83.73
Low: $82.84
High: $83.78

50 Day Range

MA: $88.07
Low: $82.94
High: $92.86

52 Week Range

Now: $83.73
Low: $74.41
High: $94.04

Volume

565,808 shs

Average Volume

683,192 shs

Market Capitalization

$9.84 billion

P/E Ratio

19.75

Dividend Yield

2.28%

Beta

0.74

Frequently Asked Questions

What sell-side analysts currently cover shares of Amdocs?

The following sell-side analysts have issued stock ratings on Amdocs in the last twelve months: Barclays PLC, Citigroup Inc., Jefferies Financial Group Inc., Oppenheimer Holdings Inc., Robert W. Baird, Stifel Nicolaus, and StockNews.com.
View the latest analyst ratings for DOX.

What is the current price target for Amdocs?

0 Wall Street analysts have set twelve-month price targets for Amdocs in the last year. Their average twelve-month price target is $101.83, suggesting a possible upside of 21.6%. Barclays PLC has the highest price target set, predicting DOX will reach $111.00 in the next twelve months. Robert W. Baird has the lowest price target set, forecasting a price of $90.00 for Amdocs in the next year.
View the latest price targets for DOX.

What is the current consensus analyst rating for Amdocs?

Amdocs currently has 1 hold rating and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for DOX.

What other companies compete with Amdocs?

How do I contact Amdocs' investor relations team?

Amdocs' physical mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company's listed phone number is (314) 212-7000 and its investor relations email address is [email protected]. The official website for Amdocs is www.amdocs.com. Learn More about contacing Amdocs investor relations.